Characteristics of blood rheology in patients during novacor left ventricular assist system support

被引：0
|
作者：
Hung, T.-C. [1 ]
Butter, D.B. [1 ]
Kormos, R.L. [1 ]
Sun, Z. [1 ]
Borovetz, H.S. [1 ]
G riffith, B.P. [1 ]
Yie, C.-L. [1 ]
机构：
[1] Department of Neurosurgery and Surgery, University of Pittsburgh, Pittsburgh, PA 15213, United States
来源：
ASAIO Transactions | 1989年 / 35卷 / 03期
关键词：
Biological materials--Blood - Biomedical engineering--Hemodynamics - Pumps--Medical Applications - Rheology;
D O I：
10.1097/00002216-198907000-00144
中图分类号：
学科分类号：
摘要：
Blood rheologic properties were studied in 11 patients on Novacor LVAS support (1-126 days) as a bridge to transplantation. Overall, these patients showed slight increases in mean blood viscosity and red cell rigidity. Their mean plasma fibrinogen was in the upper normal range. However, the degree of rheologic change observed, and the individual factors affected most, were unique to each patient and hemorheologic results correlated well with the patient's clinical status.
引用
收藏
页码：611 / 613
相关论文
共 50 条
  • [21] Echocardiography and synchronisation of a Novacor left ventricular assist device
    Léger, P
    Fellahi, JL
    Philippe, E
    Pavie, A
    Gandjbakhch, I
    Coriat, P
    ANESTHESIOLOGY, 1998, 89 (3A) : U252 - U252
  • [22] Neurologic complications of the novacor left ventricular assist device
    Thomas, CE
    Jichici, D
    Petrucci, R
    Urrutia, VC
    Schwartzman, RJ
    ANNALS OF THORACIC SURGERY, 2001, 72 (04): : 1311 - 1315
  • [23] Longest time of support by the Novacor left ventricular assist device without pump exchange
    Potapov, EV
    Weng, Y
    Drews, T
    Jurmann, M
    Hetzer, R
    ANNALS OF THORACIC SURGERY, 2005, 80 (06): : 2421 - 2421
  • [24] Initial clinical experience with a wearable controller for the Novacor left ventricular assist system
    Miller, P.J.
    Billich, T.J.
    LaForge, D.H.
    Lee, J.
    Naegeli, A.
    Ramasamy, N.
    Jassawalla, J.S.
    Portner, P.M.
    ASAIO Journal, 1994, 40 (03)
  • [25] Severe aortic valve fusion after nearly three years of support with the Novacor left ventricular assist system
    Nishimura, M
    Ohtake, S
    Sawa, Y
    Fukushima, N
    Matsumiya, G
    Matsuda, H
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (01): : 179 - 180
  • [26] Comparison of the CardioWest total artificial heart, the novacor left ventricular assist system and the thoratec ventricular assist system in bridge to transplantation
    Copeland, JG
    Smith, RG
    Arabia, FA
    Nolan, PE
    Mehta, VK
    McCarthy, MS
    Chisholm, KA
    ANNALS OF THORACIC SURGERY, 2001, 71 (03): : S92 - S97
  • [27] The importance of blood rheology in left ventricular assist device therapy
    Chowdhury, Mohammed
    Maharaj, Valmiki
    Agdamag, Arianne
    Edmiston, Blair
    Nzemenoh, Bellony
    Charpentier, Victoria
    Alexy, Tamas
    BIORHEOLOGY, 2021, 58 (3-4) : 113 - 114
  • [28] Novacor left ventricular assist device inflow valve endocarditis
    Gazzoli, Fabrizio
    Grande, Antonino Massimiliano
    Pagani, Francesco
    Vigano, Mario
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 35 (05) : 910 - 910
  • [29] Recent improvements in outcome with the novacor left ventricular assist device
    Strauch, JT
    Spielvogel, D
    Haldenwang, PL
    Correa, RK
    deAsla, RA
    Seissler, PE
    Baran, DA
    Gass, AL
    Lansman, SL
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (06): : 674 - 680
  • [30] Cost analysis of the Novacor Left Ventricular Assist System as an outpatient bridge to heart transplantation
    Arabia, FA
    Smith, RG
    Jaffe, C
    Wild, JC
    Rose, DS
    Nelson, RJ
    McClellan, DM
    Acuna, GA
    Edling, NG
    Harrington, NK
    Rabago, G
    Tsen, AC
    Arzouman, DA
    Sethi, GK
    Copeland, JG
    ASAIO JOURNAL, 1996, 42 (05) : M546 - M549
12345